An Iterative Bayesian Approach to Health Technology Assessment: Application to a Policy of Preoperative Optimization for Patients Undergoing Major Elective Surgery

Purpose . This article presents an iterative framework for managing the dynamic process of health technology assessment. The framework uses Bayesian statistical decision theory and value of information (VOI) analysis to inform decision making regarding appropriate patient management and to direct future research effort over the lifetime of a technology. Within the article, the framework is applied to a policy decision regarding preoperative patient management before major elective surgery, for which trial data are available. Method . The evidence available prior to the trial is used to determine the appropriate method of patient management and to ascertain whether, at the time of commissioning, the trial was potentially worthwhile. The prior information is then updated with the trial data via a Bayesian analysis using informative priors. This post trial information set is then used to reassess the appropriate method for patient management and to determine whether there is a requirement for any further research. Results . Prior to the trial, preoperative optimization with dopexamine is identified as the appropriate method of patient management. The results of the VOI analysis suggest that a short-term trial was potentially worthwhile (population expected value of perfect information [EVPI] = £48 million). Following the trial, the uncertainty surrounding the choice of appropriate patient management and the potential worth of further research had increased (population EVPI = £67 million). Conclusions . The article demonstrates the value and practicality of applying the iterative framework to the dynamic process of health technology assessment. It is only by formally incorporating all of the information available to decision makers, through informed priors, that the appropriate decisions can be made.

[1]  David B. Dunson,et al.  Bayesian Data Analysis , 2010 .

[2]  David R. Jones,et al.  Bayesian methods in health technology assessment: a review. , 2000, Health technology assessment.

[3]  K R Abrams,et al.  Decision analytical economic modelling within a Bayesian framework: application to prophylactic antibiotics use for caesarean section , 2002, Statistical methods in medical research.

[4]  John D. Graham,et al.  Going beyond the single number: Using probabilistic risk assessment to improve risk management , 1996 .

[5]  H. Raiffa,et al.  Introduction to Statistical Decision Theory , 1996 .

[6]  M C Weinstein,et al.  Bayesian value-of-information analysis. An application to a policy model of Alzheimer's disease. , 2001, International journal of technology assessment in health care.

[7]  D. Spiegelhalter,et al.  Bayesian Approaches to Clinical Trials and Health-Care Evaluation: Spiegelhalter/Clinical Trials and Health-Care Evaluation , 2004 .

[8]  George Woodworth Modeling in Medical Decision Making: A Bayesian Approach , 2007 .

[9]  Reducing the risk of major elective surgery: randomised controlled trial of preoperative optimisation of oxygen delivery , 1999 .

[10]  J Hjelmgren,et al.  Health economic guidelines--similarities, differences and some implications. , 2001, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[11]  I. Woods,et al.  Reducing the risk of major elective surgery: randomised controlled trial of preoperative optimisation of oxygen delivery , 1999, BMJ.

[12]  O. Boyd,et al.  A cost analysis of a treatment policy of a deliberate perioperative increase in oxygen delivery in high risk surgical patients , 1997, Intensive Care Medicine.

[13]  M. Drummond,et al.  The Iterative Use of Economic Evaluation as Part of the Process of Health Technology Assessment , 1997, Journal of health services research & policy.

[14]  Robert Schlaifer,et al.  Probability And Statistics For Business Decisions , 1960 .

[15]  Anthony O'Hagan,et al.  Eliciting expert beliefs in substantial practical applications , 1998 .

[16]  Kimberly M. Thompson,et al.  The Value of Improved National Exposure Information for Perchloroethylene (Perc): A Case Study for Dry Cleaners , 1997 .

[17]  M. A. Best Bayesian Approaches to Clinical Trials and Health‐Care Evaluation , 2005 .

[18]  M. Drummond,et al.  A rational framework for decision making by the National Institute For Clinical Excellence (NICE) , 2002, The Lancet.

[19]  A E Ades,et al.  Expected Value of Sample Information Calculations in Medical Decision Modeling , 2004, Medical decision making : an international journal of the Society for Medical Decision Making.

[20]  S B Thacker,et al.  The case for reassessment of health care technology. Once is not enough. , 1990, JAMA.

[21]  Peter Green,et al.  Markov chain Monte Carlo in Practice , 1996 .

[22]  H. Raiffa,et al.  Applied Statistical Decision Theory. , 1961 .

[23]  J O Chinnis,et al.  BAYESIAN COST-EFFECTIVENESS ANALYSIS , 2001, International Journal of Technology Assessment in Health Care.

[24]  D G Clayton,et al.  A Monte Carlo method for Bayesian inference in frailty models. , 1991, Biometrics.

[25]  Karl Claxton,et al.  Pre-operative optimisation employing dopexamine or adrenaline for patients undergoing major elective surgery: a cost-effectiveness analysis , 2002, Intensive Care Medicine.

[26]  E. Bennett,et al.  A randomized clinical trial of the effect of deliberate perioperative increase of oxygen delivery on mortality in high-risk surgical patients. , 1993, JAMA.

[27]  W. Shoemaker,et al.  Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. , 1988, Chest.

[28]  J Lipscomb,et al.  Assessing Uncertainty in Cost-Effectiveness Analyses , 1997, Medical decision making : an international journal of the Society for Medical Decision Making.

[29]  K Claxton,et al.  An economic approach to clinical trial design and research priority-setting. , 1996, Health economics.

[30]  Gordon B. Hazen,et al.  Sensitivity Analysis and the Expected Value of Perfect Information , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[31]  D. Rubin The Bayesian Bootstrap , 1981 .

[32]  K Claxton,et al.  The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. , 1999, Journal of health economics.

[33]  K Claxton,et al.  Bayesian approaches to the value of information: implications for the regulation of new pharmaceuticals. , 1999, Health economics.

[34]  M. Sculpher,et al.  Representing uncertainty: the role of cost-effectiveness acceptability curves. , 2001, Health economics.

[35]  K R Abrams,et al.  Bayesian methods in meta-analysis and evidence synthesis. , 2001, Statistical methods in medical research.